NANOBIOTIX Provides Business Update and Financial Results
Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel...
Source: globenewswire.com
Page 2 - Single Agent Activated News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Single Agent Activated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Single Agent Activated Today - Breaking & Trending Today
NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update
Reported €30.2 million in cash and cash equivalents as of March 31, 2023PARIS and CAMBRIDGE, Mass., May 17, 2023 -- NANOBIOTIX , a late-clinical stage biotechnology company pioneering... | May 17, 2023
Source: marketscreener.com
Nanobiotix: CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
Source: finanznachrichten.de
Nanobiotix: NANOBIOTIX Provides First Quarter Operational and Financial Update
On-track to activate first US clinical trial sites in on-going pivotal phase III global registration study, NANORAY-312, in locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in Q3
Source: finanznachrichten.de
NANOBIOTIX Provides First Quarter Operational and Financial Update
18.05.2022 - Regulatory News: NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the 'Company'), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced operational ... Seite 1
Source: wallstreet-online.de